Softwr

Research · head to head

Form Bio vs Terra

Form Bio logo

Form Bio

Research

Computational platform for cell and gene therapy design and manufacturability

From
On request
Rated
-
Full reviewWebsite
Terra logo

Terra

Research

Open biomedical research platform for genomic analysis, priced only by the cloud you consume

From
Free
Rated
-
Full reviewWebsite

The short version

  • Only Terra has a free tier, so it costs nothing to try first.
  • Each has a real cost: Form Bio the company has pivoted twice since spinning out of Colossal Biosciences in 2022, from general computational life sciences to cell and gene therapy and then to AAV manufacturability, so any evaluation more than a year old describes a product that is no longer the commercial focus.; Terra the absence of a licence fee hides the real cost driver: an idle notebook virtual machine left running overnight, or a workspace bucket full of intermediate workflow outputs, quietly consumes grant money with no vendor invoice to prompt a review.
  • They diverge on capability: Form Bio covers FormManufacturing, Terra covers No platform licence fee.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which Form Bio and Terra actually diverge.

Attributes where Form Bio and Terra differ
AttributeForm BioTerra
Starting priceOn requestFree
Pricing modelquoteOpen source, no licence fee
Free tierNoYes
PlatformsWeb, CloudWeb, Google Cloud, Microsoft Azure

Identical on both: user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Form Bio

  • FormManufacturing
  • Payload design optimisation
  • Genome integrity analysis
  • Manufacturability prediction
  • In silico workflows
  • Scale-up monitoring
  • Cell and gene therapy focus
  • Collaboration

Only in Terra

  • No platform licence fee
  • Cloud pass-through billing
  • WDL workflow execution
  • Notebook environments
  • Controlled-access data
  • Workspace sharing
  • Compliance posture
  • Multi-cloud

What people use each for

The jobs each tool is most often brought in to do.

Form Bio

  • A gene therapy developer discovering manufacturability problems with an AAV construct late in process development and wanting to move that analysis earliernot Terra
  • A biotech comparing several candidate payload designs in silico before committing to expensive production runsnot Terra
  • A CDMO characterising what a client construct actually produces against what was specifiednot Terra
  • A programme team needing genome integrity evidence to support regulatory conversations about product consistencynot Terra

Terra

  • A genomics lab running whole-genome alignment and variant calling pipelines without provisioning or maintaining a local clusternot Form Bio
  • A consortium sharing controlled-access human data across institutions where the data cannot be copied to each sitenot Form Bio
  • A health system analysing patient genomic data under a HIPAA business associate agreementnot Form Bio
  • A federal or federally funded project needing FedRAMP Moderate authorisation for its analysis environmentnot Form Bio

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Form Bio

  • The company has pivoted twice since spinning out of Colossal Biosciences in 2022, from general computational life sciences to cell and gene therapy and then to AAV manufacturability, so any evaluation more than a year old describes a product that is no longer the commercial focus.
  • The current offering launched AAV-focused, so developers working in lentiviral, mRNA or cell therapy modalities are outside the scope the platform was built and validated for.
  • No pricing is published and engagements are scoped per programme, which makes it impossible to size the commitment before entering a sales process.
  • This is a young venture-funded company whose analyses feed regulatory-facing decisions, so continuity of the vendor over a multi-year development programme is a genuine diligence question rather than a formality.
  • Predictive manufacturability models need real production data to be trustworthy, and the value depends on how much of that a young vendor has accumulated, which is difficult for a buyer to verify independently.

Terra

  • The absence of a licence fee hides the real cost driver: an idle notebook virtual machine left running overnight, or a workspace bucket full of intermediate workflow outputs, quietly consumes grant money with no vendor invoice to prompt a review.
  • Cost governance is entirely the customer responsibility, and grant-funded groups without a cloud engineer routinely overspend before anyone reads the Google or Azure bill in enough detail to find the cause.
  • It assumes genuine bioinformatics competence: writing or adapting WDL workflows, managing data tables and debugging failed tasks are all on you, so a wet lab without computational staff cannot use it productively.
  • Feature parity between the Google Cloud and Azure deployments is not identical, so a decision on cloud provider constrains which capabilities and datasets you can reach and is expensive to reverse later.
  • It is a research platform rather than a regulated clinical system: it is not a validated GxP environment and does not carry the qualification package a diagnostic or submission workflow would require, so clinical use needs additional infrastructure and validation you provide yourself.

Pricing, plan by plan

Form Bio

On request
  • FormManufacturing$undefined/year
    • Pricing only through a sales process
    • Scoped per therapeutic programme rather than per seat
    • AAV-focused offering at launch

Terra

Free
  • Terra platformFree
    • No charge for the platform, administration, security controls or frontline support
    • Workspaces, workflow execution and notebook environments included
    • Available on Google Cloud and Microsoft Azure
  • Cloud consumption$undefined/month
    • Google Cloud or Azure charges passed through at cost with no markup
    • Running notebook virtual machines around 0.22 USD per hour, roughly 0.027 USD per hour when paused
    • Storage billed continuously on workspace buckets and intermediate workflow outputs

Which should you pick?

Choose Form Bio if

  • You need formmanufacturing.
  • You work on Web, Cloud.
  • You also want payload design optimisation.
Form Bio review

Choose Terra if

  • You need no platform licence fee.
  • You want to start without paying.
  • You work on Web, Google Cloud, Microsoft Azure.
  • You also want cloud pass-through billing.
Terra review

Questions people ask

Is Form Bio or Terra better?
Neither clearly leads. Form Bio starts at On request and Terra at Free, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Form Bio or Terra?
Terra has a free tier; the other does not. Paid plans start at On request for Form Bio and Free for Terra.
Does Form Bio or Terra run on more platforms?
Form Bio runs on Web, Cloud. Terra runs on Web, Google Cloud, Microsoft Azure.
Can I use Terra for free?
Yes. Terra has a free tier, so you can try it without paying. Form Bio starts at On request.
What is Form Bio best used for?
Form Bio is most often used for a gene therapy developer discovering manufacturability problems with an aav construct late in process development and wanting to move that analysis earlier, a biotech comparing several candidate payload designs in silico before committing to expensive production runs, a cdmo characterising what a client construct actually produces against what was specified, a programme team needing genome integrity evidence to support regulatory conversations about product consistency. Of those, a gene therapy developer discovering manufacturability problems with an aav construct late in process development and wanting to move that analysis earlier and a biotech comparing several candidate payload designs in silico before committing to expensive production runs are not what Terra is typically brought in for.
What can Form Bio do that Terra cannot?
Form Bio covers FormManufacturing, Payload design optimisation, Genome integrity analysis, Manufacturability prediction. Terra covers No platform licence fee, Cloud pass-through billing, WDL workflow execution, Notebook environments.

Answered from the vendors’ own pages

Form Bio: What does Form Bio sell now?

FormManufacturing, launched in 2026, an AAV-focused platform for predicting, optimising and monitoring manufacturability of genetic medicines from construct design through scale-up.

Terra: Is Terra really free?

The platform is. There is no licence fee. Everything you pay is Google Cloud or Azure compute, storage and egress, passed through at cost.

Form Bio: Is it still a general bioinformatics platform?

No. It has narrowed from broad computational life sciences tooling to cell and gene therapy, and within that to AAV.

Terra: What actually drives the bill?

Running virtual machines and stored data. Pausing notebooks drops a virtual machine from about 0.22 to about 0.027 dollars an hour, and deleting intermediate workflow outputs is the other main saving.

Form Bio: Where did the company come from?

It spun out of Colossal Biosciences in 2022.

Terra: Can I use it with protected health information?

Yes. Terra signs HIPAA business associate agreements and GDPR data processing agreements, and the Azure deployment holds FedRAMP Moderate authorisation.

Form Bio: Is pricing published?

No. Engagements are scoped per programme through a sales process.

Terra: Is it validated for clinical or GxP use?

No. It is a research platform. Regulated clinical or submission workflows need validation and controls you build yourself.

Share

Related pages

More on Form Bio

More on Terra

Keep looking

Other head to heads